Literature DB >> 18773895

The genetic basis of primary biliary cirrhosis: premises, not promises.

Pietro Invernizzi, M Eric Gershwin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18773895      PMCID： PMC2629658          DOI： 10.1053/j.gastro.2008.08.020

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  36 in total

Review 1.  Genome-wide association studies for complex traits: consensus, uncertainty and challenges.

Authors:  Mark I McCarthy; Gonçalo R Abecasis; Lon R Cardon; David B Goldstein; Julian Little; John P A Ioannidis; Joel N Hirschhorn
Journal:  Nat Rev Genet       Date:  2008-05       Impact factor: 53.242

2.  Cytotoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis.

Authors:  Peter Donaldson; Sivakumar Veeramani; Anna Baragiotta; Annarosa Floreani; Carla Venturi; Simon Pearce; Valerie Wilson; David Jones; Oliver James; John Taylor; Julia Newton; Margaret Bassendine
Journal:  Clin Gastroenterol Hepatol       Date:  2007-05-07       Impact factor: 11.382

Review 3.  The causes of primary biliary cirrhosis: Convenient and inconvenient truths.

Authors:  M Eric Gershwin; Ian R Mackay
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

4.  Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis.

Authors:  January T Salas; Jesús M Banales; Sarai Sarvide; Sergio Recalde; Alex Ferrer; Iker Uriarte; Ronald P J Oude Elferink; Jesús Prieto; Juan F Medina
Journal:  Gastroenterology       Date:  2008-02-14       Impact factor: 22.682

Review 5.  CTLA-4: a key regulatory point in the control of autoimmune disease.

Authors:  Kenneth J Scalapino; David I Daikh
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

6.  Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis.

Authors:  Monica Miozzo; Carlo Selmi; Barbara Gentilin; Francesca R Grati; Silvia Sirchia; Sabine Oertelt; Massimo Zuin; M Eric Gershwin; Mauro Podda; Pietro Invernizzi
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

7.  Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease.

Authors:  Eckart Schott; Heiko Witt; Maria Pascu; Florian van Boemmel; Viola Weich; Alexandra Bergk; Juliane Halangk; Tobias Müller; Gero Puhl; Bertram Wiedenmann; Thomas Berg
Journal:  Eur J Gastroenterol Hepatol       Date:  2007-11       Impact factor: 2.566

8.  Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis.

Authors:  Brian D Juran; Elizabeth J Atkinson; Erik M Schlicht; Brooke L Fridley; Gloria M Petersen; Konstantinos N Lazaridis
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

Review 9.  CTLA-4: From conflict to clinic.

Authors:  Hema Bashyam
Journal:  J Exp Med       Date:  2007-06-11       Impact factor: 14.307

10.  Liver autoimmunity triggered by microbial activation of natural killer T cells.

Authors:  Jochen Mattner; Paul B Savage; Patrick Leung; Sabine S Oertelt; Vivien Wang; Omita Trivedi; Seth T Scanlon; Krishna Pendem; Luc Teyton; John Hart; William M Ridgway; Linda S Wicker; M Eric Gershwin; Albert Bendelac
Journal:  Cell Host Microbe       Date:  2008-05-15       Impact factor: 21.023
View more
  14 in total

Review 1.  Primary biliary cirrhosis and liver transplantation.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara
Journal:  Intractable Rare Dis Res       Date:  2012-05

Review 2.  Update on primary biliary cirrhosis.

Authors:  Pietro Invernizzi; Carlo Selmi; M Eric Gershwin
Journal:  Dig Liver Dis       Date:  2010-03-31       Impact factor: 4.088

3.  Immune-mediated bile duct injury: The case of primary biliary cirrhosis.

Authors:  Carlo Selmi; Andrea Affronti; Laura Ferrari; Pietro Invernizzi
Journal:  World J Gastrointest Pathophysiol       Date:  2010-10-15

Review 4.  Experimental evidence on the immunopathogenesis of primary biliary cirrhosis.

Authors:  Carlo Selmi; Francesca Meda; Anaid Kasangian; Pietro Invernizzi; Zhigang Tian; Zhexiong Lian; Mauro Podda; M Eric Gershwin
Journal:  Cell Mol Immunol       Date:  2009-12-23       Impact factor: 11.530

5.  Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI.

Authors:  Henrik Nilsson; Lennart Blomqvist; Lena Douglas; Anders Nordell; Eduard Jonas
Journal:  HPB (Oxford)       Date:  2010-10       Impact factor: 3.647

6.  Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients.

Authors:  Yoshihiro Aiba; Minoru Nakamura; Satoru Joshita; Tatsuo Inamine; Atsumasa Komori; Kaname Yoshizawa; Takeji Umemura; Hitomi Horie; Kiyoshi Migita; Hiroshi Yatsuhashi; Makoto Nakamuta; Nobuyoshi Fukushima; Takeo Saoshiro; Shigeki Hayashi; Hiroshi Kouno; Hajime Ota; Toyokichi Muro; Yukio Watanabe; Yoko Nakamura; Toshiki Komeda; Masaaki Shimada; Naohiko Masaki; Tatsuji Komatsu; Michiyasu Yagura; Kazuhiro Sugi; Michiaki Koga; Kazuhiro Tsukamoto; Eiji Tanaka; Hiromi Ishibashi
Journal:  J Gastroenterol       Date:  2011-05-19       Impact factor: 7.527

7.  Genetic susceptibility to autoimmune liver disease.

Authors:  Jochen Mattner
Journal:  World J Hepatol       Date:  2011-01-27

8.  Genomic variants associated with primary biliary cirrhosis.

Authors:  Carlo Selmi; Natalie J Torok; Andrea Affronti; M Eric Gershwin
Journal:  Genome Med       Date:  2010-01-26       Impact factor: 11.117

Review 9.  Infliximab as a treatment option for patients with rheumatoid arthritis and primary biliary cirrhosis.

Authors:  Despoina Dimopoulou; Theodoros Dimitroulas; Evangelos Akriviadis; Alexandros Garyfallos
Journal:  Rheumatol Int       Date:  2015-09-28       Impact factor: 2.631

Review 10.  Primary biliary cirrhosis.

Authors:  Simon Hohenester; Ronald P J Oude-Elferink; Ulrich Beuers
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.